Szu‐Ta Chen

Harvard University

Papers

1

Total Citations

38

H-Index

1

About

Dr. Szu‐Ta Chen is a leading health services researcher whose work centers on comparative effectiveness, surgical outcomes, and the economic evaluation of cancer care. His major contributions lie in using large-scale, population-based databases to assess real-world treatment outcomes, particularly for colorectal cancers. In a landmark 2017 study, he conducted a propensity score-matched analysis of the Nationwide Inpatient Sample, comparing open, laparoscopic, and robotic surgical treatments for rectal cancer. This work, which has garnered 38 citations, provided critical evidence on the trade-offs between clinical outcomes and hospital costs across surgical modalities. By rigorously controlling for patient selection bias, Dr. Chen’s research offers actionable insights for surgeons, policymakers, and patients navigating complex treatment decisions. His work exemplifies how big data analytics can bridge the gap between clinical trials and everyday practice, helping to optimize both the quality and affordability of surgical oncology care. For students and researchers, Dr. Chen’s studies serve as a model for conducting high-impact, policy-relevant comparative effectiveness research using administrative data.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of outcome and cost among open, laparoscopic, and robotic surgical treatments for rectal cancer: A propensity score matched analysis of nationwide inpatient sample data
38 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Harvard University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago